Imaging experts analyzed 11 years' worth of data to help providers proactively identify fractures that may require further scrutiny.

The analysis supports a potential role for omecamtiv mecarbil in the treatment of severe HF.

Backed by private equity firm Wellspring Capital, Rayus is acquiring the Diagnostic Centers of America and its eight locations in Florida.

The company recently canceled its Q2 earnings call and had hoped to file financials by Oct. 15, but officials said Tuesday that it's not going to happen. 

The findings are from a survey of the nation’s “leading” medical groups and integrated health systems, commissioned by the AMGA. 

Together they'll read more than 130 million exams annually and serve 2,000 customers including the 10 top U.S. hospitals, the two said. 

Many clinicians are quick to praise the tool's convenience, but a pair of experts say solid diagnostic evidence is still lacking.

The application was granted a rare pediatric disease voucher by the FDA.

Many patients say their understanding comes from radio, TV or social media, but nearly 70% would rather sit down with an imaging expert to discuss radiation issues.

“Our study adds additional evidence that patients with minor stroke or TIA should be started on DAPT irrespective of their pretreatment antiplatelet status,” the researchers wrote.